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Abstract
Background: The microarray has contributed to developing the omic analysis. However, as it depends basically on
the surface reaction, it is hard to perform bulk reactions and sequential multistep reactions. On the other hand, the
popular microplate technology, which has a great merit of being able to perform parallel multistep reactions, has
come to its limit in increasing the number of wells (currently, up to 9600) and reducing the volume to deal with
due to the difficulty in operations.
Results: Here, we report a novel microarray technology which enables us to explore advanced applications,
termed microarray-with-manageable volumes (MMV). The technical essence is in the pipette-free direct parallel
transfer from well to well performed by centrifugation, evading the evaporation and adsorption-losses during
handling. By developing the MMV plate, accompanying devices and techniques, generation of multiple conditions
(256 kinds) and performance of parallel multistep reactions, including PCR and in vitro translation reactions, have
been made possible. These were demonstrated by applying the MMV technology to searching lysozyme-
crystallizing conditions and selecting peptides aimed for Ab-binding or cathepsin E-inhibition.
Conclusions: With the introduction of a novel concept microarray (MMV) technology, parallel and multistep
reactions in sub-μL scale have become possible.
Background
Introduction of the microarray has brought about a
revolutionary change in biological studies, leading to the
development of omic world studies: genome, transcrip-
tome, proteome, and others [1,2]. The microarray tech-
nology has a wide range of applications and is still
developing. Among the most common applications,
there are cDNA and oligonucleotide chips [3,4] and
expression array of proteins [5,6]. Much advanced appli-
cations are appearing as the living protein chip [7,8]. In
essence, the current microarray technology is based on
the surface reaction allocated at each spot. Therefore, in
a microarray experiment, the elements of reactants (e.g.,
a set of mRNAs expressed in a particular cell) can be
sorted and arrayed by a set of counter-reactants (e.g.,
oligonucleotides of different sequences) at a single
operation, saving laborious experiments and costly
reagents. For the researcher’s convenience, microarrays
which deal with a high density of information need to
be supplied commercially due to the requirement of ela-
borate apparatuses and software. Obviously, most of the
data obtained by the microarray technology could not
have been addressed by any other method, featuring the
exceptional power of this technology.
Nevertheless, the current microarray technology still
leaves room to be developed. One of the emerging desires
to it is the ability of multistep operations and reactions:
e.g., if an mRNA binding to a particular oligonucleotide
c o u l db et r a n s l a t e di n t oap r o t e i nin situ and then could
be monitored about the function of the product (protein),
functional analyses of proteins would be much boosted
up. On the other hand, in an in vitro evolution study, a
huge number of clones (more than 10
3-4)n e e dt ob e
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small amount (less than μL) and highly parallel (more than
thousands) and multistep operations are required [9-12].
In other words, the conventional micro-plate (96- and
384-wells) technology, though it allows us to operate in
multisteps, requires not a tiny amount of reagents (more
than 10 μL or so) if we consider the high degree of paralle-
lism. Therefore, technologies dealing with less than μL ali-
quots have been pursued. Although there are not a few
studies on dealing with sub-μL solutions [13-15], they are
basically microfluidics approaches and are currently lim-
ited in the degree of parallelism and the number of possi-
ble reaction steps [16]. This may be because they are
adopting, in a sense, a closed system so as to prevent from
evaporation-loss of a tiny volume of sample, leading to
rather elaborate and complicated systems. Another
approach to earn the multiplicity and smallness of samples
is the beads-based one [17] and the essence of it has been
successfully adopted in the machine of giga-base (next-
generation) sequencers [18]. However, in this approach,
there is a difficult problem to cope with: multi-parallel and
multistep reactions require the compartmentation of
beads. This has already been challenged by some scientists
[19]. We made a quite different, unique approach for this
challenge: open well type compartmentation.
In this stream, we have devised a multi-well type
microarray (open system) made of plastics (dry) and gel
(wet) and developed its operational method through
pilot experiments such as an arrayed-colony formation,
a parallel monitoring of various conditions (for crystalli-
zation), and an application to multistep reactions. To
develop such technologies, fabricating microarrays in-
house was actually prerequisite. As is well-known, the
conventional microarray technology has been developed
based on the highly sophisticated photo-lithographic
technology developed for the IC industry [20]. There-
fore, the technological framework was well-established
and rather easy to attain a high density of arrays (e.g.,
millions per square inches). Though the IC-derived
technology is good at surface reactions, this technology
developed for handling ‘information (state)’ but not
‘materials (molecules)’ has a limitation in being applied
to a bulk reaction of molecules. One typical inconveni-
ence is, as shown in Fig. 1, in the inability to succeed
individual reaction products at each spot for the next
reaction independently, thus making the parallel multi-
step reactions impossible. Since almost all reactions
in vitro need to be multistep ones, a number of separate
tubes (or their collective form termed as microplate)
have been traditionally used with an aid of robotics,
resulting in a massive system [21-23]. Currently, the
number of wells per micro-plate has boosted up to
almost the limit of 3456 to 9600 with increase of diffi-
culties in operation time and throughput accuracy [24].
In this paper, a novel method depending on a wet and
dry microarray system was developed, which enables
parallel operations of sub-μL aliquots by overcoming
difficult problems such as measuring and transferring
sub-μL solutions in parallel without critical evaporation
and adsorption-losses of samples. As a result, multi-
different conditions were formed for crystallization of
proteins and multistep reactions were successively per-
formed in parallel beginning with PCR followed by tran-
scription, translation, modifying enzyme reaction, and
protease-activity assay. Thus, this paper reports a great
potentiality of a novel concept microarray MMV for the
first time.
Results and discussion
First, we need to describe how to make and handle
the novel microarray MMV and then proceed to its
applications.
Introduction of microarray with manageable volumes
(MMV): how to make and operate
Following the methods described in Methods, the MMV
was prepared and operated (see Fig. 2). MMVs were fab-
ricated using the apparatus built in-house which is com-
posed of DMD (Digital Multi-mirror Device) and others
(Fig. 2a) [25,26]. We could form any type of vessels, fil-
ters, templates, and others made of either plastics or gel
through light-induced polymerization by controlling the
light pattern generated by DMD (Fig. 2b-d). MMVs
made of gel (wet type) were first introduced here and
used in combination with plastics MMVs (dry type) to
fulfill multistep reactions as described in Methods. The
basic operation of sample transfer from one to another
MMV is an aperture-to-aperture way as shown in
Fig. 3a and Fig. 3e. In order to demonstrate the feasibil-
ity of multistep reactions in the MMV, DNA encoding
green fluorescent protein (GFP) was PCR-amplified
using an MMV (see ‘MMV operations’ in Methods and
Additional file 1). The amplified DNA molecules were
transferred to another MMV, partly filled with a solu-
tion for the transcription/translation reaction, and then
subjected to the reaction. The resulting checker pattern
of fluorescent GFP proteins (see Fig. 4) confirmed the
success of the parallel aperture-to-aperture transfer and
the series of reactions: PCR, transcription, and transla-
tion which finally generate fluorescent GFPs (see ‘Verifi-
cation of the MMV transfer operation’ in Methods).
Without using pipettes, each well of an MMV can be set
to be differently conditioned (‘multi-conditioning’)b y
using various forms of sample-supplying MMVs (Fig. 3c
and Fig. 3f). In other words, applying a sample to a par-
ticular well can be fulfilled by making the corresponding
well chargeable as shown in Fig. 3f. On the other hand,
solutions in each well can be transferred to a facing well
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Page 2 of 16in the opposing MMV in parallel, if necessary, separat-
ing magnet-bead-trapped molecules from the remaining
solvent and solutes as shown in Fig.3d. Therefore, com-
bining these operations, samples in each well can be
independently manipulated at will without using pip-
ettes, which is one of the most remarkable features of
the MMV technology. Since handling of ~0.1 μL or less
aliquots can not evade from the instant evaporation pro-
blem during the ejection of them from a microsyringe,
this feature is valuable in addition to the rapid transfer.
Besides, 1000-fold parallelism is another great problem
in handling such a minute volume of solution even if
a 
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Figure 1 Advantages of the MMV (microarray-with-manageable volumes). In the conventional microarray, reaction products diffuse away
(Panel a) while in the MMV each reaction product can stay in the same site (well) (Panel b). Another merit of the MMV is that each well of an
MMV can be treated individually, leading to parallel multistep reactions. In these experiments, the volume of an MMV well can be changed
quantitatively as shown in this figure.
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Page 3 of 16robotics could be employed. This has been a common
challenge for MEMS (mechano-electro micro system)
and μTAS (micro-Total Analysis System) approaches
[13-15,27,28], but yet not completely solved. Therefore,
a direct transfer, aperture-to-aperture (Fig. 3e), system is
an effective solution for this problem.
To make this system working, both wet and dry
MMVs were necessary to be used compensatively: wet
one is required for PCR and cell-cultivation while dry
one can be used repeatedly for the other purposes such
as exchange of solutions. This complementary usage of
wet and dry MMVs enabled us to perform multistep
reactions which contain molecule-amplification (PCR)
reactions as shown later.
Application to a crystallization condition test
To generate multiple conditions (256 species), ‘2
N method’
was employed using dry MMVs. In case of generating 256
different conditions, 8 species of MMV plates (2
N =2 5 6 ;
then N = 8) were used for this purpose (see Fig. 3f and
Fig. 5). The transfer was carried out by spinning two face-
to-face stacked MMV plates, a recipient MMV (bottom)
and a donor MMV (top) (Fig. 3e). Using the MMV thus
made, we could obtain four distinctive types of crystals:
typical, micro, needle-like and amorphous crystals (Fig. 6)
corresponding to the phase diagram in Fig. 7. This result
informs us that the conditions of the lower NaCl concen-
trations (0.2~0.4 M) and the pH of around 4~5 were espe-
cially suitable for obtaining a large tetragonal crystalline
a
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Figure 2 How to generate and operate MMVs. (a) MMV generator. (b) A projection pattern used for 1000 well type (actually 988 wells for
samples and 3 guide holes). (c) An example of a plastic MMV (1024 well type). (d) Procedures for generating an MMV. Namely, i) place a
bedding plate (plastics or pre-molded gel) in a container, ii) pour the monomer solution (for either plastics or gel formation), iii) irradiate the
pattern-carrying light (see Fig. 2b), iv) remove the non-polymerized solution (blank) and, finally, v) get an MMV (yellow).
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Page 4 of 16Figure 3 Basic sample-handling procedures. (a) Digital (discrete) addition of samples into MMV wells. (b) Initial filling an MMV with sample
solution. Aero-bubbles are removed by centrifugation. (c) Two ways of regulatory replica-transfer: template way and filtering way. (d) Magnetic
separation of beads. During the centrifugation, magnetic beads can resist against falling owing to the magnetic force. (e) Replica-transferring of
samples into recipient MMV wells. (f) Template MMVs (T0~T7) used for selective introduction of samples. These 8 patterns of MMVs can generate
256 species of different conditions (see Fig.5).
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Page 5 of 16and that the higher salt concentration (0.9~1.5 M) and the
lower pH (pH 3~4) conditions generated the needle-like
crystalline whereas the other conditions led to poor gen-
eration of crystallines. Such systematic information on
crystallization conditions must be very useful for the
physicochemical study of morphogenesis mechanism
[29-32]. By applying this method, the cost-performance
can be greatly improved due to the tiny scale (sub-μL) of
this method and, otherwise unavailable experiments must
be made possible (see ‘2
N Method’ in Methods).
ab
Figure 4 MMV applications. (a) Trial version of MMV handling. DNAs encoding the GFP gene charged in checker-patterned wells are PCR-
amplified there and then transferred to another MMV where the transcription and translation experiments were performed, resulting in the
expression of fluorescent GFP proteins. The variation in the fluorescence intensity came from rather weak controlling of transferred volumes (not
completely eliminating lateral (side) transfer during the transfer by centrifugation), which should be conquered in future. (b) Photograph of a
checker-patterned MMV. Well patterns of an MMV can be freely designed as described in Fig. 2d. For the sake of clarity, we chose a checker
pattern to verify the transfer operation. Here, an MMV made of acrylamide gel is shown.
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Figure 5 2
N method. Each well on an MMV can be addressed using the binary number. For example, in case of 16 wells-MMV (16 = 2
4, N = 4),
address-allotting becomes as shown in the center of this figure. If we regard each order (bit) corresponding to a different element (in this case,
color), then 4 different (orthogonal) elements need to be prepared. If we take ‘1’ as ‘add’ and ‘0’ as ‘not add’, each binary addressing
corresponds to directing which elements should be added there. So, the template way (see Fig. 3c) requires 4 different template plates as
shown in this figure. By using these four templates, 16 different states can be prepared in an MMV.
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Figure 6 Lysozyme crystallization. In 256 different conditions, four distinctive types of crystals: typical, micro, needle-like and amorphous
crystals were obtained. Some of the wells of an MMV are shown as inset (close-up images).
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Figure 7 Phase diagram of the crystallization of lysozyme. Four distinctive types of crystals were obtained under the various ionic strength
and pH conditions. Each state of crystallization is shown: yellow (typical crystal), green (needle-like crystal), blue (micro-crystal), gray (amorphous
one), and white (undetected).
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In addition to the plastic MMV made of PDMS (polydi-
methylsiloxane) or acrylate resin as a dry type, we ori-
g i n a l l yi n t r o d u c e daw e tt y p eM M Vm a d eo f
polyacrylamide gel. To validate wet MMVs used for cul-
tivation, bacteria E. coli harboring green fluorescent pro-
tein (GFP) were subjected to a single cell culture (i.e.,a
single cell per well (expectation value)). Overnight cul-
ture of the cells in the MMV resulted in a Poisson dis-
tribution as expected (Fig. 8). This means that we could
obtain neatly arrayed colonies without depending on
robotics such as Colony Picker [33], which can be easily
manipulated in the following processes.
The power of wet MMVs was partly shown above in
the success of the PCR-containing experiment (Fig. 4)
since the dry MMVs could not have provided a success-
ful PCR due to the drying-up during the PCR thermal
cycle. Clearly, the wet gel must have protected the dry-
ing up effect of samples by serving as a reservoir against
evaporation. Importantly, whether wet or dry MMVs are
used, coating the surface of MMVs with BSA (1 mg/
mL) was indispensable for successful reactions.
Application of MMVs to multistep screening experiments
Two independent applications of MMVs were carried
out: (a) selection of Amyloid b (Ab)-binding peptides
and (b) selection of cathepsin E inhibitory peptides.
First, the selection of Ab-binding peptides was per-
formed, consisting of 5 consecutive steps of reaction:
PCR-amplification of DNA, in vitro transcription,
in vitro translation, binding of Ab and Ab-binding pep-
tides, and monitoring the fluorescence of GFP (which is
expressed as a protein fused with Ab-binding peptides,
thus serving as a marker) with three exchanges of
MMV plates. The final result of these reactions is the
Ab-binding peptides as shown in Fig. 9 where those
wells which contain GFP-fused peptides trapped by Ab
on a magnetic bead are illuminating (dark wells). Those
wells where GFPs are expressed and halted (Ab-binding
peptides with a sufficient binding affinity with Ab can
be expected there) indicate the success of a series of
reactions. The background brightness is caused by the
reflection of the excitation beam on the surface of sam-
ple solutions. In this experiment, the peptide sequences
could be obtained from the corresponding DNAs con-
t a i n e di nt h es a m ew e l lb yP C R( d a t ao b t a i n e da r e
shown in Table 1).
As another example of multistep reactions, selection
of cathepsin E-inhibitory peptides was performed using
MMV plates. For the multistep experiment, wet MMV
plates were used for DNA amplification by PCR (start-
ing with 50 molecules of template DNAs [34]), in vitro
transcription/translation, restriction protease (Xa) diges-
tion, and cathepsin E-inhibition assay (The MMV plate
plan used is schematically shown in Fig. 10a). After all,
the wells containing cathepsin E-inhibitory peptides
were marked as a dark spot (Fig. 10b). The contents in
t h o s ew e l l sw e r ef u r t h e ra n a l y z e db yD N As e q u e n c i n g
and the CE-inhibitory peptides were identified (see
Additional file 2). Through this experiment, MMVs
were again confirmed to be usable for multistep reac-
tions including PCR.
Conclusions
We have first introduced a novel concept microarray
that can handle sub-μL scale bulk reactions, which
enables 1000-fold parallel and multistep reactions. For
this purpose we fabricated wet and dry microarrays with
manageable volumes (MMVs). MMVs could be used for
setting multi-different conditions and for culturing cells
in an array mode (Fig. 6, Fig. 7 and Fig. 8). Especially,
MMVs were powerful for in vitro selection experiments
as shown regarding the selections of Ab-binding pep-
tides and CE inhibitory ones (Fig. 9 and Fig. 10). Con-
clusively, the MMV has two prominent merits: an ability
to generate multiple conditions (1000-fold and more)
and another ability to succeed well-specific products
well-to-well (leading to multistep parallel reactions).
Both were proven effective experimentally in this paper.
We sometimes experienced mis-transfers in the aper-
ture-to-aperture (well-to-well) mode because of side
diffusion in-between two MMVs (partly discussed in
Fig. 4). This problem must be solved controlling the
quality of MMVs (Recently, this was verified by an
Figure 8 MMV cultivation of E. coli. GFP-expressing cells of E. coli
were detected by fluorescence with a fluoroimager (FITC mode):
Dark wells indicate fluorescent colonies of E. coli.
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Page 8 of 16experiment using MMVs made of PDMS (data not
shown)). This technology is relatively free from the pro-
blems of evaporation (see Additional file 3) and adhe-
sion losses owing to the direct transfer from well to well
and the introduction of wet vessels made of gel. Since
the volume of a solution is measured by the capacity of
a well, there are some errors in the volume precision by
around 10% or so, which is still permissible for the cur-
rent studies. Moreover, this fault must be conquered by
t h ei m p r o v e m e n to ft h es u r f a c en a t u r eo fd r yM M V s
(which sometimes work as a scale). Therefore, sub-μL
volume, which is almost beyond the pipette operation,
could be first manipulated quantitatively without
depending on pipettes.
Finally, drawing a possible application of the MMV
technology must be helpful to visualize the utility of this
novel one. Namely, we will be able to fabricate a protein
chip more conveniently and effectively than currently
done. The procedures will be: i) make an oligonucleotide-
array based on the conventional microarray technology,
ii) trap cDNAs by hybridization at each cognitive oligo-
nucleotide spot, iii) transfer each DNA parallelly to each
corresponding well of an MMV by electrophoresis or dif-
fusion (from spot to aperture), iv) do successive reactions
Table 1 Selected Ab binding peptides
Round/Clone No. Nucleotide sequence (5’to 3’) Peptide sequence (10a.a.)
1/1 TGC ATT ATT ATT ATT TGG GAA CAC TCC TGC CIIIIWEHSC
1/2 TGC ATT ATG TCC ATT CTC CTC ATT GTG TGC CIMSILLIVC
1/3 TGC AAT AAT ACA GCG CCA AGT CAT AAT TGC CNNTAPSHNC
2/1 TGC ATG TGG TGG ATT CCA ATT AAA CGT TGC CMWWIPIKRC
2/2 TGC TGG GTA ATT TGG ATT GTG ATT ATG TGC CWVIWIVIMC
Figure 9 Selection of Ab-binding peptides performed in a 1000-wells MMV. (a) Those wells which contain Ab-binding peptides are
indicated by an arrow (bright wells due to the fluorescence of the fused GFP). (b) DNA construct of the variable peptide-library. PT7 designates
T7 promoter and franked by other regulatory sequences for transcription/translation of the gene. GFP means the green fluorescent protein gene.
GFP is used for detection of peptide binding to Ab on the magnetic beads. His tag and FLAG region are used for purification and detection of
the protein. Xa is the recognition sequence for the restriction cutting of protease Xa. Variable region encodes the sequence of various peptides.
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Page 9 of 16Figure 10 Selection of cathepsin E (CE)-inhibitory peptides. (a) An MMV plate plan adopted for the selection of CE-inhibitory peptides. First,
magnetic beads were added to MMV1 and transferred to MMV2. MMV2 was changed with a cell-free transcription/translation solution.
Independently, MMV3 was subjected to amplification of DNA (PCR reaction) and the products were transferred to MMV2. After transcription and
translation reactions in MMV2, generated proteins were treated with restriction protease Xa, releasing peptides from the protein bound on the
magnetic bead. After removal of magnetic beads, the supernatant was transferred to MMV5 which contains cathepsin E and its fluorogenic
substrate. After incubation, the fluorescent product was monitored with a fluoroimager. The symbol ‘arrow with a spiral’ means that the
preceding MMV is layered upside down as a donor MMV to the following one (recipient MMV). (b) Selection of CE-inhibitory peptides. In this
case, dark wells contain CE-inhibitory peptides which block the CE enzyme reaction (generation of fluorescent products) and result in no
production of fluorescent products. The arrows in inset indicate the inhibitory peptide-containing wells.
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Page 10 of 16in MMVs including PCR, in vitro transcription and
in vitro translation on beads within a well, v) transfer the
resultant peptides/proteins on beads on a chip surface
and fix there by a tag sequence or else, completing a pro-
tein chip. This approach will drastically reduce the cost
and labor to make arbitrarily designed protein chips. The
protein chip thus constructed must be used for ‘proteo-
mic diagnosis’ which aims to survey all biomarkers such
as cancer, diabetes, neurodegenerative diseases, and
others at once and quantitatively. To be encouraging
enough, in vitro evolution utilizing the MMV itself (partly
shown in Fig. 9 and Fig. 10) must be able to find such
biomarkers.
Methods
Tools and methods to construct the system of microar-
ray-with-manageable-volumes (shortly, MMV) have
been developed in this study, including an MMV gen-
erator, various types of MMV plates (made of gel or
plastics with wells of different size and number), MMV
containers for centrifugation and incubation and sample
transfer/solution preparation methods.
MMV-generator and MMV
MMVs were fabricated using a home-made apparatus,
MMV generator which contains DMD (digital multi-
mirror device) projector LVP-XD10 (Mitsubishi, Japan)
with the optical system modified (Fig. 2a). This appara-
tus can project any light pattern under the direction of
computer and thus can polymerize gel/plastics, of which
reaction can be initiated by light irradiation, in an arbi-
trary shape (Fig. 2b). A typical dry MMV (1024 wells/
inch
2) is shown with the dimension of a well (Fig. 2c)
and how to fabricate an MMV is depicted (Fig. 2d).
Both types of MMVs, wet and dry, were developed
using acrylamide aqueous solution and acrylate (pen-
taerythritol tri-acrylate; Aldrich, Germany), respectively.
For the generation of polyacrylamide gel (wet MMV),
18% acrylamide solution (acrylamide:bis-acrylamide =
19:1) containing 0.27 mM riboflavin and 70% sucrose,
was used. For acrylate resin (dry MMV), pentaerythritol
tri-acrylate, containing 0.45% bis(2,4,6-trimethylbenzoil)-
phenylphosfinoxide IRGACURE®819 (Ciba, Japan) and
0.05% 2-hydroxy-2-nethyl-1-phenyl-propane-1-on DAR-
OCUR®1173 (Ciba, Japan), was used. After a brief light
irradiation using mercury-lump VLT-X10P (Osram,
Germany), unpolymerized solutions were immediately
removed by jet-water (in case of wet MMV) or by spin-
ning off (in case of dry MMV). The wet MMV was
further subjected to a buffer-exchanging process to
remove riboflavin, acrylamide monomers and sucrose
and replace with an appropriate solution. Thus, the
plate of a wet MMV was usually equilibrated with a
reaction solution without large molecules such as
peptides and DNAs. The swelling/shrinking effect of
gels during these processes was kept carefully within
control. The dry MMV was finally washed in a labware
detergent 7-X ES PF (Dainippon Pharm. Co., Japan)
with sonication.
MMV operations
Due to the great number (~1000) and the smallness
(~0.5 μL) of samples, one-by-one transfer of them is
neither reasonable nor realistic. Therefore, we adopted
the most direct approach for transferring samples from
an MMV to an MMV by attaching two MMVs (donor
MMV and recipient MMV) face-to-face and then preci-
pitating by spinning (aperture-to-aperture transfer) and
found this working. We further developed necessary
techniques for handling MMVs: charging, addition, and
selective addition (filtering or template method) of sam-
ples, measuring up to a volume, mixing, incubation (cul-
tivation or enzymatic reacti o n ) ,P C R ,s e p a r a t i o ni n t o
solid and liquid parts.
a) Charging/Addition
Initial charging of sample solution into each well can be
performed by spinning of a pool of solution placed on
the top surface of MMV, resulting in filling all the wells
with the solution and the remaining solution overflowed
over the rim (see Fig. 3b). In case of adding another ali-
quot to the content of a well in an MMV, a transfer
from the concerned MMV to an MMV having deeper
wells (recipient MMV) was carried out in advance and
then an additive transfer from an MMV (donor MMV)
was made (see Fig. 3a). Further additions can be done
until the recipient MMV is filled up.
(Development of a robotics is effective but not essen-
tial for most experiments.)
b) Selective addition (filtering/template method)
In those cases which require addition of a solution to
particular wells, we can adopt either a filtering layer
method or a template-like MMV one. The filtering layer
placed between From- and To-MMVs enables the selec-
tive transfer from wells for which the filtering layer is
open (penetrable). On the other hand, a template MMV
can hold samples in those wells which were made open
when the MMV was fabricated and thus can transfer
samples selectively from those wells (see Fig. 3c).
c) Measuring up the volume
T h i sc a nb ed o n ea sa na p p l i c a t i o no faddition process
(see above) if the size of the well of a donor-MMV is
made unitary (of a fixed volume). N-times of addition
make N units of volume input into a recipient-MMV.
d) Mixing
A l t h o u g hs u c hat i n yv o l u m ea ss u b - μL is rather favor-
able for diffusion and thermal conductance, it is very
unfavorable for mixing solutions with a vortex. For this
purpose, we made a target molecule (peptide) bound on
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force. In other cases, stirring the solution with vigorous
moving of small steel balls (~0.4 mm in diameter; Super
micro-ball generously provided by Toyo Seiko Co.,
Japan) by magnetic force was also applied, of which
effect was confirmed by diffusion of dye.
e) Incubation (cultivation/enzymatic reaction)/PCR
In case of culturing of bacteria, an MMV plate was
equilibrated by soaking with LB broth or Davis medium
prior to the culture and a container with a large space
(more than 18 cm
3) equipped with a water reservoir was
selected. For a PCR reaction, the MMV plate was placed
in a small container (5.4 cm
3) firmly sealed to avoid an
evaporation loss during incubation and held in a cham-
ber thermally controlled (Mastercycler gradient, Eppen-
dorf Co., Germany). PCR was carried out in a special
device for the sake of effective heat conductance and
minimum evaporation of water (see Additional file 1).
The PCR program adopted was as follows: pre-heating,
94°C, 2 min; denaturing, 94°C, 0.5 min; annealing, 55°C,
1m i n ;e x t e n s i o n ,7 2 ° C ,1m i n( 3 5c y c l e s ) ;p o s te x t e n -
sion, 72°C, 5 min.
f) Separation into a solid and a liquid parts
By attracting magnetic beads upward out of the liquid
with a magnet, the solid (beads) and the liquid were
easily separated (see Fig. 3d).
g) Image processing (fluorescence/optical light)
A newly made MMV was treated to equilibrate with a
permeation solution (50 mM sodium acetate, 0.1 M
NaCl, pH 4.5) containing 5 μM fluorogenic substrate of
cathepsin E (CE) MOCAc-Gly-Lys-Pro-Ile-Ile-Phe-Phe-
Arg-Leu-Lys(DnP)-D-Arg-NH2 (Code 3200-V, Peptide
Institute, Inc., Osaka), and was half-filled with a CE
reaction solution (permeation solution containing 5 μM
substrate and 5 pmol CE additively). This reaction mix-
ture was transferred to a translation MMV by centrifu-
gation (1500 rpm, 20 s). The mixture was incubated at
37°C for 10 min with a shaking incubator Bioshaker V.
BR-36 (TAITEC, Saitama). Then, the fluorescence of the
product in the MMV was measured with a fluoroimager
GelDoc XR (BioRad, USA) using 0.008% K2CrO4 aqu-
eous solution as an excitation filter (320-340 nm) and a
glass plate as an emission filter (<360 nm cut-off).
h) In vitro transcription and translation using an MMV
A wet MMV was treated to equilibrate with a permea-
tion buffer for reverse transcription (13 mM magnesium
acetate, 50 mM Hepes-KOH, 100 mM potassium gluta-
mate, 20 mM creatine phosphate, 2 mM spermidine,
1m Md i t h i o t h r e i t o l ,2m MA T P ,2m MG T P ,1m M
CTP, 1 mM UTP, and 0.3 mM amino acid mix, pH 7.6).
For in vitro transcription and translation, Wako pure
system (Wako, Tokyo) was used and the reaction mix-
ture was prepared following the manufacturer’si n s t r u c -
tions. Streptavidin-coated magnetic beads (TaKaRa,
Kyoto) suspended in 80 μL (0.4 mg) and pre-washed
repeatedly with 100 μL of water and the binding solu-
tion (TaKaRa, Kyoto) were combined and then added to
every well of the MMV to half a well volume by manu-
ally pouring or controlled centrifugation. The MMV
subjected to PCR (PCR MMV) was spun to precipitate
solutions to the bottom before the following operation.
In rare cases, some wells were readjusted to half a
volume of the well with the PCR solution. Then, the
PCR MMV was combined face-to-face to a translation
MMV fitting the apertures in a correct phase with the 4
corners pinned and fixed. PCR solutions were trans-
ferred into each well of the translation MMV by centri-
fugation (1500 rpm, 20 s). The reaction solutions were
stirred by moving magnetic beads up and down by
attracting with a neodymium magnet (20 times). The
mixtures were then incubated at 37°C for 2 h with
further stirring at 20 min intervals as described above.
Polymerase Chain Reaction (PCR) in MMV
A PCR mixture was prepared as recommended by man-
ufacture’s instruction (SpeedSTAR HS DNA polymerase
TaKaRa, Kyoto), added optionally with an enzyme stabi-
lizer (Lipidure BL-802 (NOF Corp. Tokyo)), and input
into wells of a wet-type MMV which had been equili-
brated in advance with PCR buffer containing PCR com-
ponents except template DNA, Taq polymerase, and
primers. The MMV was placed within a PCR container
which was hand-made from silicon rubber and stainless-
steel sheets (see Additional file 1). The container was
placed in a thermal cycler and PCR amplification was
performed with a program (pre-denaturation, 94°C,
2 min; denaturation, 94°C, 1 min; annealing, 55°C,
1 min; extension, 72°C, 1 min (35 cycles); and post-
extension, 72°C, 5 min). The MMV plate was removed
from the container and the content was recovered after
centrifugation. The DNA amplification with this system
was confirmed by gel-electrophoresis and silver staining
(see Additional file 1).
Verification of the MMV transfer operation
To demonstrate the effectiveness of the well-to-well
transfer and successive reactions, we constructed and
tried a model experiment. A checker-patterned MMV
was filled with a PCR solution containing 2 fmole/μLo f
DNA coding GFP as templates, respectively. SpeedSTAR
polymerase (TaKaRa, Kyoto) was used for a rapid ampli-
fication and the PCR program was utilized as follows:
pre-denature, 94°C, 2 min; denature, 94°C, 20 s; anneal-
ing and extension, 1 min (25 cycles); and post-extension,
72°C, 2 min. After PCR procedures (see ‘MMV opera-
tions’ in Methods), the contents of the MMV were
transferred to another MMV which was partly filled
with a cell-free transcription/translation solution
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was incubated at 37°C for 1 h. The fluorescent image
was monitored with a fluoroimager and the checkered
fluorescent image was obtained. The consistence
between the PCR well-pattern and the fluorescent image
of GFP verified the fidelity of MMV transfer operations
(see Fig. 4).
2
N Method
In the case of micro-arrays which have a 2
N ×2
N square
well-pattern ("N” designates a natural number), its
whole diversity (2
2N) can be generated by employing
“2N” kinds of quite different (orthogonal) elements.
“2N” kinds of elements can be easily prepared by using
“2N” sheets of filters (by considering the symmetrical
nature of filters, “N” is sufficient) which have rather
simple well patterns. In the case of “N” =2( s e eF i g .5 )
for example, 2 sheets of filter are sufficient to be pre-
pared and each filter can be used in two ways, working
virtually as four template plates. Four kinds of elements
are transferred into a recipient microarray by centrifuge.
Finally, all of the 16 wells of the microarray would have
different constituents from each other. Each well can be
uniquely assigned by the binary number. If we regard
the digit ‘1’ as ‘exist’ and ‘0’ as ‘non-exist’ and if we con-
sider the difference of the order in the number corre-
sponds to the difference of elements in the actual
experiment, then the well assigned 1001 (9 in the deci-
mal number) should contain the elements corresponding
to the elements #1 and #4 (#1-#4 corresponds to the
MSB, 2nd MSB, 3rd MSB and LSB). Here, we utilized a
256-well micro-array ("N” = 4) for examining condition
on re-crystallization of lysozyme (see Fig. 2f where we
can confirm that the pairs of T0/T4, T1/T5, T2/T6, and
T3/T7 are symmetrical).
Selection of Ab aptamers
The DNA construct for in vitro transcription/translation
(see Fig. 9b) was amplified using the following primers
in the PCR reaction: P1, 5’GATCCCGCGAAATTAA-
TACGACTC ACTATA3’;a n dP 2 ,5 ’GGCTCGCGAA-
TACTGCGAAGGAGTGAGATC3’.Ap a r to ft h e
translation mixture and the magnetic beads were
removed from the translation MMV using a magnet. On
the other hand, Ab peptides were trapped on magnetic
beads as follows: an aliquot containing 50 μLM a g n o t e x
SA particle (TaKaRa, Kyoto) was mixed with biotin-
labeled Ab peptide solution (5 μg/50-500 μL) in a bind-
ing buffer. After incubation for 20 min at room
temperature, the beads were washed and re-suspended
with 500 μL PBS buffer (pH 7.0). For each selection
round, 2 mg of beads, which have approximately 500
pmoles of bound Ab (1-42), was used. Magnetic beads-
Ab conjugates were inputted into a fresh MMV to make
each well containing 0.050 pmoles (0.5 μL) of the conju-
gate. Then, the conjugate suspension was spun down
into a translation MMV and the solution in the wells
was mixed by moving the magnetic beads up and down
with a magnet. The suspension was incubated at 37°C
for 1 h with several 20 min-interval mixings. With fixing
the magnetic beads with a magnet on the bottom of
well, the solution was transferred to a fresh MMV by
centrifugation. The fluorescence of GFP bound on beads
was monitored with a fluoroimager. After selection of
Ab-binding peptides by fluorescence intensity, the sepa-
rated supernatants were used as a template solution for
PCR for the next round of selection and DNA sequen-
cing to confirm the Ab-binding peptides.
Library construction and selections
a) Library construction
Combinatorial DNA and IVV (in vitro virus)-peptide
libraries were constructed according to the previously
reported method of YLBS [35] and cDNA display [36].
b) Preparation of CE-immobilized beads used for selection
Purified cathepsin-E (CE) was immobilized on NHS-
activated sepharose beads (GE Healthcare, USA) by
using the amine coupling chemicals to form a chemi-
cally stable amide bond in accordance with the manu-
facturer’s instructions. The enzyme-coupled beads were
stored in 100 mM phosphate buffer (pH 7.4) at 4°C
until further use. The coupling efficiency was calculated
by comparing the absorbance of uncoupled enzyme with
that of free enzyme.
c) Affinity-based selection
The IVV-peptide library in 100 μL of Selection buffer
(50 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl2,p H
7.2) was mixed with 5 μL of CE-immobilized beads and
incubated at 25°C for 30 min. The beads were washed
with 200 μL of Selection buffer, Washing buffer-1 (50
mM Tris-HCl, 0.5 M NaCl, pH 7.2) and Washing buf-
fer-2 (50 mM Tris-HCl, 1 M NaCl, pH 7.2) in accor-
dance with the protocol of washing repeat count, which
varied along the selection round, i.e., 2:2:1 in Round 1;
2:2:2 in Round 2; 3:3:3 in Round 3. Finally, the beads
were suspended in 200 μL of Elution buffer-1 (50 mM
Tris-HCl, 1 M NaCl, 10 mM MgCl2,p H7 . 2 )a n di n c u -
bated at 37°C for 5 min. After centrifugation (1500 rpm,
1 min), the beads were washed again with Elution buf-
fer-1. The combined supernatant was stored (Sup1). The
beads were suspended with Elution buffer-2 (50 mM
Tris-HCl, 2 M NaCl, 10 mM MgCl2,p H7 . 2 )a n di n c u -
bated at 95°C for 5 min. After incubation, the beads
were removed and the supernatant was stored (Sup 2).
The IVVs in Sup1 and Sup 2 were purified with a Bio-
Spin column (Bio-Rad Laboratories, USA).
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The DNA library resulting from Round 3 of the affinity-
based selection was inserted in the IVV-SF-link DNA
construct as a variable region [36]. The IVVs were pre-
pared and incubated as described in affinity-based selec-
tion. The protocol of washing repeat count with
Selection buffer, Washing buffer-1 and Washing buffer-2
was carried out according to the selection round program
(F1 to F9) as follows: 3:3:3 in F1, 4:5:3 in F2, 5:5:5 in F3,
5:7:5 in F4, 5:7:7 in F5, 5:10:7 in F6, 5:10:10 in F7, 5:15:10
in F8, and 5:15:15 in F9.
Sample preparation
a) GFP-expressing Escherichia coli
The buffer components in a gel-MMV plate (1 × SSC)
were exchanged with LB broth and the affluent solution
in wells was removed by centrifugation. Overnight cul-
ture of E. coli cells harbouring green fluorescence pro-
tein (GFP) was diluted with LB broth to the
concentration of one cell per well (0.5 μL) and then put
into wells of an MMV by centrifugation. The MMV was
layered on a wet tissue paper in a petri dish and sub-
jected to the incubation at 37°C. The fluorescence of
GFP expressed in E. coli cells was monitored with a
fluoroimager, Molecular Imager FX (Bio-Rad Labora-
tories, USA).
b) A DNA library for cathepsin E-inhibitory peptides
A DNA library was constructed, of which DNA encodes
a different species of a cathepsin E-binding peptide (8-
28 amino acids in size) which is derived from the pre-
ceding in vitro selection experiment [36] (see ‘ Library
construction and selection’ and Fig. 11).
c) Lysozyme solutions
Lysozyme provided in lyophilized powder (protein con-
tent, ~95%; ~50,000 units/mg protein (Sigma-Aldrich,
Germany)) was dissolved in distilled water (250 mg/mL)
using a vortex mixer with a special care so as not to
leave visible flocs and then spun down. The supernatant
was used for the crystallization experiment.
Generation of combinatorial conditions (2
N method)
We applied the 2
N method (see ‘2
N Method’ and Fig. 5)
using a 256-well MMV to generating 256 species of condi-
tions aimed for crystallization of lysozyme. The ionic
strength and pH were modulated using the following
NaCl and sodium acetate-HCl buffers, respectively. Each
template MMV of T0~T7 was charged with 0.1 μLo f2M
NaCl (T0), 3 M NaCl (T1), 4 M NaCl (T2), 5 M NaCl
(T3), pH 3 (T4), pH 4 (T5), pH 5 (T6), and pH 7 (T7),
respectively. To make the final solution volume equal in
each well, the complementary volume of water was added
to those wells which were not charged with any of T0~T7
solutions, using the complementary templates T0~T7
(well/non-well relations inverted). Finally, a lysozyme solu-
tion (250 mg/mL) was added (0.1 μL). The MMV was cov-
ered with a piece of transparent adhesive tape Titer Stick
(Wakenyaku, Japan) to prevent evaporation and was kept
at 20°C for several days. Each well was monitored by an
inverted microscope IM (Olympus, Tokyo).
Multistep operations of MMVs
a) In vitro selection of Ab-binding peptides
The whole procedure is described in detail above, in
which the construct and the selection of a peptide-fused
Figure 11 Schematic presentation of library-based evolutionary molecular engineering. The first library which consists of arbitrarily collected
members is subjected to the selection by affinity and then by function in the selection cycle. The selected molecules are processed to the clone-
by-clone selection. Based on the information obtained from these selections, the second library is constructed. Furthermore, the second library is
advanced to the selection cycle until identifying target peptides. MMVs can be utilized in the clonal selection. For details, see [34] in the text.
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Page 14 of 16GFP is described (see Fig. 9). Peptides were expressed by
successive reactions of PCR, in vitro transcription and in
vitro translation as written above. Then, Ab protein
(Ab4 2 )l i n k e dt oam a g n e t i cb e a dw a sa d d e db ya n
MMV-transfer (i.e., transfer from an MMV to another
MMV by centrifugation). Those peptides bound to Ab
were separated from the remaining unbound ones by
the next MMV-transfer (see ‘MMV operation’), washed
with a buffer (10 mM Tris-HCl, 1 mM EDTA, 1 M
NaCl, 0.1% NaN2), and then subjected to the fluores-
cence monitoring using fluoroimager Molecular Imager
FX (Bio-Rad Laboratories, USA) at the excitation wave-
length of 488 nm.
b) In vitro selection of cathepsin E-inhibitory peptides
A set of peptides which have a cathepsin E-inhibition
activity selected in the preceding study [34] were further
screened using MMVs (see Fig. 10). The DNA mole-
cules encoding those peptides were diluted and input in
an MMV (~50 copies per well) and then subjected to
PCR, in vitro transcription/translation, and protease Xa
digestion. Then, the magnetic beads were removed from
the MMV. The remaining solutions were used to detect
the inhibition activity of the peptide in each well. The
volume of the reaction mixtures were, if too much,
reduced to around a half-well volume by sucking with
filter paper. The measurement of the inhibition activity
in each well was carried out as described in Methods
(Image processing).
Additional material
Additional file 1: Additional Figure 1 - PCR reaction using an MMV.
(a) PCR device specialized for the microarray. Upper cover and Bottom
container were fabricated of stainless steel sheet and silicon rubber. The
microarray in the container was heat-treated via the heat block of PCR
instrument. To avoid the leakage of vapor from the container, Upper
cover was pressed with a high temperature lid which prevented the
vapor from condensing on the cover. (b) PCR product (780 bp) was
recovered by centrifuge and analyzed by polyacrylamide gel
electrophoresis and silver staining. DNA templates were amplified from
50 molecules (lane 1) and 10 molecules (lane 2) per well, respectively.
Lane “M” shows marker DNA bands (upper: 850 bp, lower: 750 bp).
Additional file 2: Additional Table 1 - Cathepsin E-inhibitory
peptides obtained by the MMV method. A list of peptides selected by
the MMV method is given.
Additional file 3: Additional Figure 2 - Evaporation rate curve.
Evaporation rates were measured with an MMV filled with water placed
on ice (square) or on the lab bench (triangle) under the conditions of
room temperature (~15°C) and humidity (47% and 58%, respectively).
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